ODDB.org: Open Drug Database

Novartis Pharma Schweiz AG - Exforge HCT 5 mg/160 mg/25 mg, Filmtabletten

Swissmedic Registration	59407	Sequence	03
Product name	Exforge HCT 5 mg/160 mg/25 mg	Description	Filmtabletten
ATC-Classification	C09DX01	ATC-Description	Valsartan, Amlodipine and Hydrochlorothiazide
Introduction of Sequence	16.09.2009

Composition

amlodipinum 5 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, E 171, E 172 (flavum), pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Amlodipine	5 mg
Hydrochlorothiazide	25 mg
Valsartan	160 mg

BAG: Active Agent	Dose
Amlodipine	5 mg
Hydrochlorothiazide	25 mg
Valsartan	160 mg

Inactive agents	Dose	additional_information
(Flavum)
Cellulosum Microcristallinum
Crospovidonum
E 171		color.
E 172		color.
Hypromellosum		Überzug
Macrogol	4000
Magnesii Stearas
Pro Compresso Obducto
Silica Colloidalis Anhydrica
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
004	28 Tablet(s)	21.99	39.95	B	SL	Yes
006	98 Tablet(s)	76.88	98.65	B	SL	Yes

2025	©ywesee GmbH